JP2016529283A5 - - Google Patents

Download PDF

Info

Publication number
JP2016529283A5
JP2016529283A5 JP2016537808A JP2016537808A JP2016529283A5 JP 2016529283 A5 JP2016529283 A5 JP 2016529283A5 JP 2016537808 A JP2016537808 A JP 2016537808A JP 2016537808 A JP2016537808 A JP 2016537808A JP 2016529283 A5 JP2016529283 A5 JP 2016529283A5
Authority
JP
Japan
Prior art keywords
composition
level
bioactive fraction
liquid
pdgf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016537808A
Other languages
English (en)
Japanese (ja)
Other versions
JP6649257B2 (ja
JP2016529283A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/052885 external-priority patent/WO2015031465A1/en
Publication of JP2016529283A publication Critical patent/JP2016529283A/ja
Publication of JP2016529283A5 publication Critical patent/JP2016529283A5/ja
Application granted granted Critical
Publication of JP6649257B2 publication Critical patent/JP6649257B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016537808A 2013-08-27 2014-08-27 濃厚血小板から誘導可能な生理活性組成物並びにその調製方法及び使用方法 Active JP6649257B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361870686P 2013-08-27 2013-08-27
US61/870,686 2013-08-27
PCT/US2014/052885 WO2015031465A1 (en) 2013-08-27 2014-08-27 Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same

Publications (3)

Publication Number Publication Date
JP2016529283A JP2016529283A (ja) 2016-09-23
JP2016529283A5 true JP2016529283A5 (enExample) 2017-10-05
JP6649257B2 JP6649257B2 (ja) 2020-02-19

Family

ID=51541312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016537808A Active JP6649257B2 (ja) 2013-08-27 2014-08-27 濃厚血小板から誘導可能な生理活性組成物並びにその調製方法及び使用方法

Country Status (11)

Country Link
US (2) US9757430B2 (enExample)
EP (1) EP3038628B1 (enExample)
JP (1) JP6649257B2 (enExample)
KR (1) KR102313054B1 (enExample)
CN (3) CN114392274A (enExample)
AU (1) AU2014312421A1 (enExample)
BR (1) BR112016004510A2 (enExample)
CA (1) CA2922205C (enExample)
ES (1) ES2837854T3 (enExample)
MX (1) MX2016002492A (enExample)
WO (1) WO2015031465A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013003356A1 (en) * 2011-06-27 2013-01-03 Emory University Compositions, uses, and preparation of platelet lysates
DE102015205293A1 (de) 2015-03-24 2016-09-29 Marc Schrott Verfahren zur Herstellung von Augentropfen
AU2016270679B2 (en) * 2015-05-29 2021-08-19 Jadi Cell Llc Particulate lyophilized platelet lysate compositions
FR3036707B1 (fr) * 2015-05-29 2019-05-17 Maco Pharma Procede de sterilisation d'un lysat plaquettaire
ES2633815B1 (es) * 2016-03-23 2018-07-06 Biotechnology Institute I Mas D, S.L. Formulación de aplicación tópica, rica en plaquetas y/o factores de crecimiento y un método de preparación de la misma
HUE067544T2 (hu) * 2016-11-18 2024-11-28 Power Of Platelets Pte Ltd Módszer növekedési faktorokat tartalmazó vérlemezke-releasate elõállítására és annak felhasználása
CN110891582A (zh) * 2017-06-16 2020-03-17 里尔大学中心医院 制备混合人血小板裂解液的方法、混合人血小板裂解液及其用于治疗神经系统疾病的用途
JP2022519781A (ja) * 2019-02-07 2022-03-24 バイオブリッジ グローバル 血小板放出物および多血小板フィブリンに関する方法および組成物
US20230270791A1 (en) * 2020-07-31 2023-08-31 Rainbow (Rainbow Inc.) Platelet lysate derived from autologous platelets
JP7313098B2 (ja) * 2021-02-26 2023-07-24 株式会社同仁がん免疫研究所 成長因子混合物を調整する方法
KR102656373B1 (ko) * 2021-06-25 2024-04-12 서울대학교병원 난소 조직 이식용 하이드로겔
EP4373951A1 (en) * 2021-07-19 2024-05-29 2seventy bio, Inc. Vector manufacturing processes
EP4276173A1 (en) * 2022-05-10 2023-11-15 Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. Stable human platelet lysate composition, methods and uses thereof
CN115125191B (zh) * 2022-08-22 2023-10-13 浙江绿蔻生物技术有限公司 成纤维细胞转化培养基及其应用、成纤维细胞的制备方法
CN119454910B (zh) * 2023-08-10 2025-10-28 四川大学华西医院 一种仿血小板凝胶修复制剂及其制备方法和促进伤口愈合的用途
WO2025085793A1 (en) * 2023-10-20 2025-04-24 Ossium Health, Inc. Compositions and methods comprising tissue implants
WO2025184489A1 (en) 2024-02-29 2025-09-04 Consano Bio, Inc. Allogeneic human plasma and platelet derived products and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520107A (en) * 1982-09-28 1985-05-28 Polydex Chemicals Ltd. Tissue culture and cell growth-promoting material and its method of manufacture
SE8801537D0 (sv) * 1988-04-26 1988-04-26 Ellco Food Ab Cellodlingsmedium samt forfarande for dess framstellning
SE528214C2 (sv) * 2005-06-23 2006-09-26 Proliff Ab Förfarande för framställning av blodplättslysat
US20090305401A1 (en) 2006-09-18 2009-12-10 Dirk Strunk Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
EP2077118A1 (en) 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
IT1392897B1 (it) * 2008-07-18 2012-04-02 Fond Ircss Ca' Granda - Ospedale Maggiore Policlinico Frazione piastrinica derivante da sangue placentare
EP2334785B2 (en) 2008-09-16 2019-08-14 Mayo Foundation For Medical Education And Research Compositions containing platelet contents
US20130017180A1 (en) * 2010-04-05 2013-01-17 Allan Mishra Platelet rich plasma formulations
CA2809272A1 (en) 2010-08-31 2012-03-08 Cook General Biotechnology Llc Systemic, allogenic stem cell therapies for treatment of diseases in animals
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
WO2013003356A1 (en) * 2011-06-27 2013-01-03 Emory University Compositions, uses, and preparation of platelet lysates
US8430521B2 (en) * 2011-07-02 2013-04-30 Jet Motor Limited Pool lighting assembly
EP2733200A1 (en) 2012-11-15 2014-05-21 Biorigen International SA Cell culture supplements
PL2956150T3 (pl) * 2013-02-12 2022-01-03 Lacerta Technologies Inc. Frakcja surowicy z fibryny bogatopłytkowej

Similar Documents

Publication Publication Date Title
JP6649257B2 (ja) 濃厚血小板から誘導可能な生理活性組成物並びにその調製方法及び使用方法
JP7122976B2 (ja) 医学に使用するためのヒト血小板溶解物由来細胞外小胞
JP7416786B2 (ja) 血小板放出物を調製するための方法
RU2016133315A (ru) Фармацевтическая композиция, содержащая эритроциты, в которых заключен фермент, зависимый от пиридоксальфосфата, и его кофактор
TW201309310A (zh) 自血液複合物獲得含生長因子組成物之方法及自該方法所獲得之組成物
CA2700500A1 (en) Desiccated biologics and methods of preparing the same
RU2015152127A (ru) Способ стабилизации суспензий эритроцитов с инкапсулированным активным ингредиентом и их получение
JP2024520486A (ja) 単核細胞－血小板リッチのフィブリンマトリックス及びその化合物を調製するための方法及びシステム
KR20120002530A (ko) 활성화된 백혈구 조성물
US12279609B2 (en) System for washing red blood cells to reduce hemolysis
JP2017171597A (ja) 血小板濃縮製剤の製造方法
JP7291972B2 (ja) 血小板を含有する血液組成物から得られる組織製剤又は接着剤、及びそのような製剤を調製する方法
Karakas et al. How can clinically-safe and effective Platelet Rich Plasma (PRP) be obtained in a laboratory?
TWI877707B (zh) 血小板裂解液的製備方法以及萃取生長因子的方法
TW201446253A (zh) 非凝集預活變形血小板之應用及其藥劑
Kahn blood insures that patients receive precisely what is need-ed, and at its optimal dosage and functional capability.
NZ748679B2 (en) Human platelet lysate or a fraction that is enriched for human platelet lysate derived extracellular vesicles for use in medicine
HK1263117A1 (en) Human platelet lysate derived extracellular vesicles for use in medicine
RU2017146209A (ru) Система из множества пакетов и способ приготовления компонентов крови